Oxford Immunotec
Abingdon
About Oxford Immunotec
Oxford Immunotec is a medical diagnostics company developing novel new tests for various diseases based on its innovative, patented T cell measurement technology. The company's first product is a TB test that diagnoses latent TB infection ( LTBI ) and TB disease. T-SPOT®.TB is an interferon gamma release assay ( IGRA ) which are designed to replace the century old Mantoux skin test ( TST ).
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Total funding: $216.5M
- Funding stage: M&A
- Last round: Post-IPO Debt (Oct 2016)
- Ticker: nasdaq:OXFD
- Website: oxfordimmunotec.com
- Phone: +44 1235 442780
Industries & Categories
Biotechnology, Health Care, Health Diagnostics
Social Profiles
Canonical: https://fsome.com/organization/oxford-immunotec-169795 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.